Your browser doesn't support javascript.
loading
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures.
Mammoli, Andrea; Coletti, Alice; Ballarotto, Marco; Riccio, Alessandra; Carotti, Andrea; Grohmann, Ursula; Camaioni, Emidio; Macchiarulo, Antonio.
Affiliation
  • Mammoli A; Department of Pharmaceutical Sciences, University of Perugia, via del liceo n.1, 06123, Perugia, Italy.
  • Coletti A; Department of Pharmacy, University of Chieti-Pescara, via dei Vestini n. 31, 66100, Chieti, Italy.
  • Ballarotto M; Department of Pharmaceutical Sciences, University of Perugia, via del liceo n.1, 06123, Perugia, Italy.
  • Riccio A; Department of Pharmaceutical Sciences, University of Perugia, via del liceo n.1, 06123, Perugia, Italy.
  • Carotti A; Department of Pharmaceutical Sciences, University of Perugia, via del liceo n.1, 06123, Perugia, Italy.
  • Grohmann U; Department of Experimental Medicine, University of Perugia, P.le Gambuli, 06132, Perugia, Italy.
  • Camaioni E; Department of Pharmaceutical Sciences, University of Perugia, via del liceo n.1, 06123, Perugia, Italy.
  • Macchiarulo A; Department of Pharmaceutical Sciences, University of Perugia, via del liceo n.1, 06123, Perugia, Italy.
ChemMedChem ; 15(10): 891-899, 2020 05 19.
Article de En | MEDLINE | ID: mdl-32190988
ABSTRACT
A large number of crystallographic structures of IDO1 in different ligand-bound and -unbound states have been disclosed over the last decade. Yet, only a few of them have been exploited for structure-based drug design (SBDD) campaigns. In this study, we analyzed the structural motifs and molecular-recognition properties of three groups of IDO1 structures 1) structures containing the heme group and inhibitors in the catalytic site; 2) heme-free structures of IDO1; 3) substrate-bound structures of IDO1. The results suggest that unrelated conformations of the enzyme have been solved with different ligand-induced changes of secondary motifs that localize even in regions remote from the catalytic site. Moreover, the study identified an uncharted region of molecular-recognition space covered by IDO1 binding sites that could guide the selection of diverse structures for additional SBDD studies aimed at the identification of novel lead compounds with differentiated chemical scaffolds.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antienzymes / Indoleamine-pyrrole 2,3,-dioxygenase Limites: Humans Langue: En Journal: ChemMedChem Sujet du journal: FARMACOLOGIA / QUIMICA Année: 2020 Type de document: Article Pays d'affiliation: Italie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antienzymes / Indoleamine-pyrrole 2,3,-dioxygenase Limites: Humans Langue: En Journal: ChemMedChem Sujet du journal: FARMACOLOGIA / QUIMICA Année: 2020 Type de document: Article Pays d'affiliation: Italie